Secondary Logo

Journal Logo

Neurological complications after cardiac surgery

anesthetic considerations based on outcome evidence

Liu, Yong; Chen, Kun; Mei, Wei

Current Opinion in Anesthesiology: October 2019 - Volume 32 - Issue 5 - p 563–567
doi: 10.1097/ACO.0000000000000755
NEUROANESTHESIA: Edited by Lingzhong Meng
Open

Purpose of review Neurological complications after cardiac surgery remain prevalent. This review aims to discuss the modifiable and outcome-relevant risk factors based on an up-to-date literature review, with a focus on interventions that may improve outcomes.

Recent findings There is a close relationship between intraoperative blood pressure and postoperative neurological outcomes in cardiac surgical patients based on cohort studies and randomized controlled trials. Adopting an optimal and personalized blood pressure target is essential; however, the outstanding issue is the determination of this target. Maintaining cerebral tissue oxygen saturation at least 90% patient's baseline during cardiac surgery may be beneficial; however, the outstanding issues are effective intervention protocols and quality outcome evidence. Maintaining hemoglobin at least 7.5 g/dl may be adequate for cardiac surgical patients; however, this evidence is based on the pooled results of thousands of patients. We still need to know the optimal hemoglobin level for an individual patient, which is of particular relevance during the decision-making of transfusion or not.

Summary The available evidence highlights the importance of maintaining optimal and individualized blood pressure, cerebral tissue oxygen saturation and hemoglobin level in improving neurological outcomes after cardiac surgery. However, outstanding issues remain and need to be addressed via outcome-oriented further research.

Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Correspondence to Wei Mei, MD, Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Road, Wuhan 430030, China. Tel: +86 27 83662673; e-mail: wmei@hust.edu.cn

This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0

Back to Top | Article Outline

INTRODUCTION

The significant improvements in both surgical techniques and anesthetic management for cardiac surgery have given millions of individuals who suffer from a life-threatening cardiovascular disease a new chance at life [1]. Although the overall perioperative mortality and morbidity has significantly reduced, neurological complications remain a major concern to this patient population [2,3].

Neurological complications secondary to cardiac surgery encompass a variety of disorders, including stroke, postoperative delirium (POD), and postoperative cognitive decline (POCD) [2,4]. The incidence of overt stroke (clinically symptomatic) ranges from 1.2 to 6%; whereas the covert stroke (clinically silent) detected by diffusion-weighed MRI occurs in as many as 50% of patients [5▪▪,6▪▪]. The reported incidence of POD ranges from 14 to 50% in cardiac surgical patients [2]; whereas POCD occurs in 25 to 50% of patients after cardiac surgery [2,5▪▪,7]. These neurological complications are associated with increased mortality, decreased quality of life and increased economic burden [4,8].

The cause of neurological complications is complex, elusive and likely multifactorial. Risk factors that are associated with various neurological complications include, but not limited to, age, history of previous stroke, preexisting cerebrovascular diseases, hypertension, atrial fibrillation, systemic inflammation, and surgical manipulation [6▪▪,9].

It should be noted that most of the risk factors, such as age and past medical history are not modifiable; whereas some factors, such as hypertension and atrial fibrillation, can be treated, optimized, and regarded as modifiable. The perioperative task is to intervene on those modifiable risk factors to further reduce neurological complications after cardiac surgery. In this review, we discuss those aspects in perioperative care that are modifiable and relevant to neurological complications after cardiac surgery based on the outcome evidence.

Box 1

Box 1

Back to Top | Article Outline

OPTIMAL BLOOD PRESSURE AND HEMODYNAMIC MANAGEMENT

The appropriate blood pressure target during cardiopulmonary bypass (CPB) has always been contentious [5▪▪,6▪▪,10–12]. Both hypotension and hypertension are deleterious. Hypotension may compromise the clearance of emboli and reduce cerebral perfusion, especially the blood flow to the watershed areas of the brain [13]. Hypertension may lead to postoperative delirium [14]. It is important to keep the blood pressure in an ideal range that is associated with the least neurological complications after cardiac surgery.

It has been common to maintain mean arterial pressure (MAP) during CPB in the range of 50 mmHg [15]. However, this empiric target of MAP has not been adequately validated. In contrast, a few randomized controlled trials (RCTs) suggests that the MAP during CBP should be maintained much higher than 50 mmHg. The RCT, performed in 248 patients undergoing coronary artery bypass grafting (CABG), showed that the strategy of maintaining a higher MAP during CPB (80–100 mmHg) led to a lower incidence of stroke compared with the strategy of maintaining a lower MAP during CPB (50–60 mmHg) (2.4 versus 7.2%) [10]. A different RCT, performed in 92 patients undergoing CABG, showed that maintaining a higher perfusion pressure during CPB (80–90 mmHg) led to a reduced incidence of POD (0 versus 13%) and a better Mini-Mental-Status scores (1.1 ± 1.9 versus 3. 9 ± 6.5) compared with the practice of maintaining a lower perfusion pressure during CPB (60–70 mmHg) [11].

A recent large retrospective cohort study based on 7457 cardiac surgical patients showed that there is a strong association between sustained MAP of less than 64 mmHg during CPB and postoperative stroke [6▪▪]. During CPB, every additional 10 min of MAP less than 55 mmHg was associated with a 16% increase in the odds of stroke, whereas every additional 10 min of MAP between 55 and 64 mmHg was associated with a 13% increase in the odds of stroke [6▪▪]. This study suggests that both the severity and the duration of hypotension during CPB are associated with the risk of stroke after cardiac surgery. Although this study suggests that the MAP should be maintained no lower than 64 mmHg during CPB, it does not inform the most ideal MAP range for this population and for individual patient in this population.

Not every study supports the linkage between a higher perfusion pressure during CPB and favorable neurological outcomes in cardiac surgery. A prospective cohort study based on 734 cardiac surgical patients did not find an association between intraoperative hypotension (MAP <50 mmHg, MAP decrease >30% relative to the baseline or MAP decrease >40% relative to the baseline) and POD [12]. The recent Perfusion Pressure Cerebral Infarcts (PPCI) RCT investigated the effect of maintaining a higher (70–80 mmHg) versus a lower (40–50 mmHg) blood pressure during CPB on postoperative brain injury diagnosed using diffusion weighted imaging [5▪▪]. This trial found that using norepinephrine to maintain a higher blood pressure did not reduce the incidence and severity of cerebral injury [5▪▪]. It must be noted that, although blood pressure was different, pump flow during CBP was maintained at the same level (2.4 l/min) for both groups in this trial. Although this study has some limitations, it challenges the findings of many previous studies [16▪].

Another direction of research is to define the optimal cerebral perfusion pressure based on cerebral pressure autoregulation, a mechanism that maintains a stable cerebral blood flow in the face of a fluctuating blood pressure [17]. However, cerebral autoregulation varies both inter-individually and intra-individually secondary to a variety of factors [18–20]. Cerebral autoregulation may also vary during a cardiac surgical procedure [21▪]. This variation challenges the practice of maintaining the MAP within the autoregulatory range. The solution may be to guide the clinical care using a monitor that continuously assesses cerebral autoregulation.

Using a moving Pearson correlation coefficient between MAP and the mean middle cerebral artery blood flow velocity or cerebral oxygen saturation, cerebral autoregulation can be assessed using mean velocity index (Mx) [22] or cerebral oximeter index (Ox) [23]. In a prospective observational study performed in 232 patients undergoing CABG, Joshi et al.[24] determined that the average lower limit of cerebral autoregulation in their patient population was 66 mmHg based on the Ox method. This value is higher than the traditionally used 50–60 mmHg threshold [17]. Importantly, the range of the lower limit of cerebral autoregulation has a wide distribution from 43 to 90 mmHg. It implies that it is easy to underestimate or overestimate the lower limit of cerebral autoregulation in an individual patient if it is not directly monitored.

In another study of 614 patients having cardiac surgery, Joshi et al. found a strong association between the product of the magnitude and duration of hypotension (by referring to the lower limit of cerebral autoregulation) and the risk of postoperative stroke based on the Mx method [25]. They showed that the lower and upper limits of cerebral autoregulation were 65 and 84 mmHg, respectively, with the optimal MAP at 78 mmHg, during CPB in their patient population [25]. They additionally showed that 17% of their patients had a lower limit of cerebral autoregulation above whereas 29% of their patients had an upper limit of cerebral autoregulation below the optimal MAP of 78 mmHg [25]. This finding suggests that even the optimal MAP for a patient population may underestimate or overestimate the optimal MAP for an individual patient.

These studies suggest that personalized MAP management based on a real-time cerebral autoregulation monitor deserves further exploration. An RCT (Cerebral Autoregulation Monitoring During Cardiac Surgery) comparing the conventional MAP management versus Mx and Ox-guided MAP management in cardiac surgery is currently ongoing (NCT00981474).

In summary, both hypotension and hypertension during cardiac surgery are detrimental to cardiac surgical patients. Optimized blood pressure management based on a personalized target is promising in further improving neurological outcomes after cardiac surgery. The outstanding question that remains to be answered is how to identify this target in an individual patient. The best hemodynamic management based on flow parameters, such as cardiac output or pump flow remains elusive.

Back to Top | Article Outline

CEREBRAL OXYGENATION-GUIDED CARE

Central nervous system can be monitored by a number of methods including processed electroencephalography and cerebral tissue oxygen saturation (SctO2) based on near-infrared spectroscopy [26,27]. The value of SctO2 is essentially determined by the balance between cerebral tissue oxygen consumption and supply [28]. The role of SctO2 monitoring in recognizing cerebral desaturation and improving neurological outcomes after cardiac surgery has been extensively studied [29–31,32▪▪].

In a prospective observational study performed in cardiac surgical patients, Yao et al.[33] found an association between intraoperative cerebral desaturation and postoperative neurological complications assessed based on a simplified antisaccadic eye movement test and Mini-Mental State Examination. In a secondary analysis of a prospective randomized trial, Holmgaard et al.[34▪▪] found a significant difference in SctO2 measurements between patients with or without new cerebral ischemic lesions after cardiac surgery. The effects of SctO2-guided intraoperative care on neurological complications after cardiac surgery have been investigated [29,30,35]. The results showed that, when SctO2 was maintained at least 75% baseline [30], at least 80% baseline [35], or near patient's baseline [29], there were fewer strokes [29,30] and a lower incidence of POCD [35]. These interventional studies suggest a causal relationship between a low SctO2 and neurologic complications after cardiac surgery and highlight the importance of maintaining an optimal intraoperative SctO2.

Not every study found a favorable effect exerted by SctO2-guided care on neurological outcomes after cardiac surgery [32▪▪]. In a recent RCT (n = 249), Lei et al.[32▪▪] found that the incidence of POD was similar in patients with and without cerebral desaturation, as well as in patients with restored and not restored SctO2.

The cause of these diverse results remains to be reconciled. It may be due to the variations in SctO2 thresholds used for intervention, the success rates in maintaining SctO2 at the target level, outcome measures, and patient characteristics [3,6▪▪,29,30,34▪▪,35]. The SctO2 threshold used for intervention was 75% baseline in Murkin et al.'s [30] study, and 80% baseline in Colak et al.'s [35] study. In Lei et al.'s [32▪▪] study, the intervention algorithm was commenced when SctO2 was less than 75% baseline for 1 min. They had an 80% success rate in maintaining SctO2 at the target level. The success rate in maintaining SctO2 at 90% baseline or above was much higher (97%) in the pilot study performed by Deschamps et al.[31].

At this time, it appears reasonable to apply a SctO2 monitor in cardiac surgical patients. It may be ideal to maintain SctO2 above 90% baseline. The intervention options include verification of head/neck position, inspection of different cannulas, increasing MAP, cardiac output or pump flow, and FiO2, avoiding hyperventilation and ‘light’ anesthesia, and red blood cell transfusion [31,35].

Back to Top | Article Outline

RED BLOOD CELL TRANSFUSION AND THE OPTIMAL HEMOGLOBIN LEVEL

Anemia is deleterious. Two large cohort studies (n = 17 056 and 10 949, respectively) demonstrated that anemia is associated with increased risk of stroke after cardiac surgery [36,37]. Severe anemia can compromise cerebral oxygen delivery, which may adversely affect the wellbeing of the brain [38].

On the contrary, red blood cell (RBC) transfusion may exert an adverse neurological effect in patients having cardiac surgery [39,40]. Patients receiving one to two units of RBC transfusion had a three-fold to four-fold increase in the risk of stroke or transient ischemic attack after cardiac surgery, and this negative effect was independent of the surgical type and the typical predictors for perioperative stroke following the adjustment by the multilevel propensity score [41]. The potential underlying mechanisms include impaired oxygen delivery at the cellular level, prothrombotic events secondary to morphological abnormalities of packed RBCs, and the release of deleterious substances from packed RBCs [41,42].

It is important to maintain hemoglobin at a level that is adequate for tissue oxygen supply, and at the same time, minimize the hazards associated with RBC transfusion. The transfusion target in cardiac surgery was a hematocrit of 20–24% based on the previous studies [5▪▪,11]. The two recently published articles by Mazer et al.[43,44▪] reported that a restrictive transfusion threshold (Hb <7.5 g/dl, n = 2430) was not inferior to a liberal transfusion threshold (Hb <9.5 g/dl, n = 2430) in cardiac surgery based on outcome measures including postoperative stroke. Nonetheless, the optimal and individualized hemoglobin level in cardiac surgical patients still deserves more research.

Back to Top | Article Outline

OTHER PROMISING DIRECTIONS

Epiaortic ultrasound is recommended before cannulation in cardiac surgery [45]. It can identify atherosclerotic lesions in the ascending aorta and allows for surgical adjustment aimed at preventing atherogenic emboli. The available evidence suggests that it may reduce the incidence of stroke in cardiac surgical patients [46–48]. Dexmedetomidine is reported to be able to reduce the incidence and duration of delirium after cardiac surgery [49,50].

Back to Top | Article Outline

CONCLUSION

Cardiac surgical patients are prone to various neurological complications. Endeavors should be made to identify those modifiable risk factors and investigate if relevant interventions can effectively reduce the incidence of various neurological complications after surgery. The available evidence suggests that maintaining an optimal and personalized blood pressure, SctO2 close to the baseline level, and hemoglobin above 7.5 g/dl during cardiac surgery may improve neurological outcomes after surgery. Further research, especially quality outcome-oriented RCTs, is needed to improve the perioperative care including neurological outcomes after cardiac surgery.

Back to Top | Article Outline

Acknowledgements

The authors thank Dr Lingzhong Meng from the Department of Anesthesiology at Yale University School of Medicine for his gracious help in improving the quality of this manuscript.

Back to Top | Article Outline

Financial support and sponsorship

None.

Back to Top | Article Outline

Conflicts of interest

There are no conflicts of interest.

Back to Top | Article Outline

REFERENCES AND RECOMMENDED READING

Papers of particular interest, published within the annual period of review, have been highlighted as:

  • ▪ of special interest
  • ▪▪ of outstanding interest
Back to Top | Article Outline

REFERENCES

1. Newman MF, Mathew JP, Grocott HP, et al. Central nervous system injury associated with cardiac surgery. Lancet 2006; 19:694–703.
2. Berger M, Terrando N, Smith SK, et al. Neurocognitive function after cardiac surgery: from phenotypes to mechanisms. Anesthesiology 2018; 129:829–851.
3. Selnes OA, Gottesman RF, Grega MA, et al. Cognitive and neurologic outcomes after coronary-artery bypass surgery. N Engl J Med 2012; 366:250–257.
4. Raffa GM, Agnello F, Occhipinti G, et al. Neurological complications after cardiac surgery: a retrospective case-control study of risk factors and outcome. J Cardiothorac Surg 2019; 14:23.
5▪▪. Vedel AG, Holmgaard F, Rasmussen LS, et al. High-target versus low-target blood pressure management during cardiopulmonary bypass to prevent cerebral injury in cardiac surgery patients: a randomized controlled trial. Circulation 2018; 137:1770–1780.

This RCT suggests that targeting a higher versus a lower blood pressure during cardiopulmonary bypass does not seem to reduce cerebral infarction in patients undergoing on-pump cardiac surgery.

6▪▪. Sun LY, Chung AM, Farkouh ME, et al. Defining an intraoperative hypotension threshold in association with stroke in cardiac surgery. Anesthesiology 2018; 129:440–447.

This large-sample retrospective study indicates both the depth and duration of hypotension is associated with postoperative stroke.

7. Knipp SC, Matatko N, Wilhelm H, et al. Cognitive outcomes three years after coronary artery bypass surgery: relation to diffusion-weighted magnetic resonance imaging. Ann Thorac Surg 2008; 85:872–879.
8. Ono M, Joshi B, Brady K, et al. Risks for impaired cerebral autoregulation during cardiopulmonary bypass and postoperative stroke. Br J Anaesth 2012; 109:391–398.
9. Hori D, Max L, Laflam A, et al. Blood pressure deviations from optimal mean arterial pressure during cardiac surgery measured with a novel monitor of cerebral blood flow and risk for perioperative delirium: a pilot study. J Cardiothorac Vasc Anesth 2016; 30:606–612.
10. Gold JP, Charlson ME, Williams-Russo P, et al. Improvement of outcomes after coronary artery bypass. A randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg 1995; 110:1302–1311. discussion 1311–1304.
11. Siepe M, Pfeiffer T, Gieringer A, et al. Increased systemic perfusion pressure during cardiopulmonary bypass is associated with less early postoperative cognitive dysfunction and delirium. Eur J Cardiothorac Surg 2011; 40:200–207.
12. Wesselink EM, Kappen TH, van Klei WA, et al. Intraoperative hypotension and delirium after on-pump cardiac surgery. Br J Anaesth 2015; 115:427–433.
13. Gottesman RF, Sherman PM, Grega MA, et al. Watershed strokes after cardiac surgery: diagnosis, etiology, and outcome. Stroke 2006; 37:2306–2311.
14. Hori D, Brown C, Ono M, et al. Arterial pressure above the upper cerebral autoregulation limit during cardiopulmonary bypass is associated with postoperative delirium. Br J Anaesth 2014; 113:1009–1017.
15. Stockard JJ, Bickford RG, Schauble JF. Pressure-dependent cerebral ischemia during cardiopulmonary bypass. Neurology 1973; 23:521–529.
16▪. Meng L, Yu W, Wang T, et al. Blood pressure targets in perioperative care. Hypertension 2018; 72:806–817.

This review discussed in depth blood pressure targets in perioperative care.

17. Lassen NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev 1959; 39:183–238.
18. Meng L, Gelb AW. Regulation of cerebral autoregulation by carbon dioxide. Anesthesiology 2015; 122:196–205.
19. Meng L, Hou W, Chui J, et al. Cardiac output and cerebral blood flow: the integrated regulation of brain perfusion in adult humans. Anesthesiology 2015; 123:1198–1208.
20. Meng L, Wang Y, Zhang L, et al. Heterogeneity and variability in pressure autoregulation of organ blood flow: lessons learned over 100+ years. Crit Care Med 2019; 47:436–448.
21▪. Caldas JR, Haunton VJ, Panerai RB, et al. Cerebral autoregulation in cardiopulmonary bypass surgery: a systematic review. Interact Cardiovasc Thorac Surg 2018; 26:494–503.

This review summarizes the influence of CBP on cerebral autoregulation and the association of clinical outcomes with changes in cerebral autoregulation.

22. Czosnyka M, Brady K, Reinhard M, et al. Monitoring of cerebrovascular autoregulation: facts, myths, and missing links. Neurocrit Care 2009; 10:373–386.
23. Zweifel C, Castellani G, Czosnyka M, et al. Continuous assessment of cerebral autoregulation with near-infrared spectroscopy in adults after subarachnoid hemorrhage. Stroke 2010; 41:1963–1968.
24. Joshi B, Ono M, Brown C, et al. Predicting the limits of cerebral autoregulation during cardiopulmonary bypass. Anesth Analg 2012; 114:503–510.
25. Hori D, Nomura Y, Ono M, et al. Optimal blood pressure during cardiopulmonary bypass defined by cerebral autoregulation monitoring. J Thorac Cardiovasc Surg 2017; 154:1590.e2–1598.e2.
26. Lewis C, Parulkar SD, Bebawy J, et al. Cerebral neuromonitoring during cardiac surgery: a critical appraisal with an emphasis on near-infrared spectroscopy. J Cardiothorac Vasc Anesth 2018; 32:2313–2322.
27. Yu Y, Zhang K, Zhang L, et al. Cerebral near-infrared spectroscopy (NIRS) for perioperative monitoring of brain oxygenation in children and adults. Cochrane Database Syst Rev 2018; 17:CD010947.
28. Meng L, Gruenbaum SE, Dai F, et al. Physiology, intervention, and outcome: three critical questions about cerebral tissue oxygen saturation monitoring. Minerva Anestesiol 2018; 84:599–614.
29. Goldman S, Sutter F, Ferdinand F, et al. Optimizing intraoperative cerebral oxygen delivery using noninvasive cerebral oximetry decreases the incidence of stroke for cardiac surgical patients. Heart Surg Forum 2004; 7:E376–E381.
30. Murkin JM, Adams SJ, Novick RJ, et al. Monitoring brain oxygen saturation during coronary bypass surgery: a randomized, prospective study. Anesth Analg 2007; 104:51–58.
31. Deschamps A, Hall R, Grocott H, et al. Cerebral oximetry monitoring to maintain normal cerebral oxygen saturation during high-risk cardiac surgery: a randomized controlled feasibility trial. Anesthesiology 2016; 124:826–836.
32▪▪. Lei L, Katznelson R, Fedorko L, et al. Cerebral oximetry and postoperative delirium after cardiac surgery: a randomised, controlled trial. Anaesthesia 2017; 72:1456–1466.

This study demonstrates that restoration of SctO2 could not reduce the incidence of postoperative delirium after cardiac surgery.

33. Yao FS, Tseng CC, Ho CY, et al. Cerebral oxygen desaturation is associated with early postoperative neuropsychological dysfunction in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2004; 18:552–558.
34▪▪. Holmgaard F, Vedel AG, Langkilde A, et al. Differences in regional cerebral oximetry during cardiac surgery for patients with or without postoperative cerebral ischaemic lesions evaluated by magnetic resonance imaging. Br J Anaesth 2018; 121:1203–1211.

This study found significant differences in SctO2 values between patients with or without new ischemic cerebral lesion after cardiac surgery.

35. Colak Z, Borojevic M, Bogovic A, et al. Influence of intraoperative cerebral oximetry monitoring on neurocognitive function after coronary artery bypass surgery: a randomized, prospective study. Eur J Cardiothorac Surg 2015; 47:447–454.
36. Ranucci M, Di Dedda U, Castelvecchio S, et al. Impact of preoperative anemia on outcome in adult cardiac surgery: a propensity-matched analysis. Ann Thorac Surg 2012; 94:1134–1141.
37. Karkouti K, Djaiani G, Borger MA, et al. Low hematocrit during cardiopulmonary bypass is associated with increased risk of perioperative stroke in cardiac surgery. Ann Thorac Surg 2005; 80:1381–1387.
38. Dhir A, Tempe DK. Anemia and patient blood management in cardiac surgery-literature review and current evidence. J Cardiothorac Vasc Anesth 2018; 32:2726–2742.
39. Paone G, Likosky DS, Brewer R, et al. Membership of the Michigan Society of Thoracic and Cardiovascular SurgeonsTransfusion of 1 and 2 units of red blood cells is associated with increased morbidity and mortality. Ann Thorac Surg 2014; 97:87–93. discussion 93-84.
40. Bahrainwala ZS, Grega MA, Hogue CW, et al. Intraoperative hemoglobin levels and transfusion independently predict stroke after cardiac operations. Ann Thorac Surg 2011; 91:1113–1118.
41. Mariscalco G, Biancari F, Juvonen T, et al. Red blood cell transfusion is a determinant of neurological complications after cardiac surgery. Interact Cardiovasc Thorac Surg 2015; 20:166–1671.
42. Koch CG, Figueroa PI, Li L, et al. Red blood cell storage: how long is too long? Ann Thorac Surg 2013; 96:1894–1899.
43. Mazer CD, Whitlock RP, Fergusson DA, et al. Restrictive or liberal red-cell transfusion for cardiac surgery. N Engl J Med 2017; 377:2133–2144.
44▪. Mazer CD, Whitlock RP, Fergusson DA, et al. Six-month outcomes after restrictive or liberal transfusion for cardiac surgery. N Engl J Med 2018; 379:1224–1233.

This study demonstrated that the transfusion threshold of Hb less than 7.5 g/dl was not inferior to that of Hb less than 9.5 g/dl regarding postoperative stroke.

45. Glas KE, Swaminathan M, Reeves ST, et al. Council for Intraoperative Echocardiography of the American Society of Echocardiography; Society of Cardiovascular Anesthesiologists; Society of Thoracic SurgeonsGuidelines for the performance of a comprehensive intraoperative epiaortic ultrasonographic examination: recommendations of the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists; endorsed by the Society of Thoracic Surgeons. Anesth Analg 2008; 106:1376–1384.
46. Ikram A, Mohiuddin H, Zia A, et al. Does epiaortic ultrasound screening reduce perioperative stroke in patients undergoing coronary surgery? A topical review. J Clin Neurosci 2018; 50:30–34.
47. Yamaguchi A, Adachi H, Tanaka M, Ino T. Efficacy of intraoperative epiaortic ultrasound scanning for preventing stroke after coronary artery bypass surgery. Ann Thorac Cardiovasc Surg 2009; 15:98–104.
48. Zingone B, Rauber E, Gatti G, et al. The impact of epiaortic ultrasonographic scanning on the risk of perioperative stroke. Eur J Cardiothorac Surg 2006; 29:720–728.
49. Wu M, Liang Y, Dai Z, et al. Perioperative dexmedetomidine reduces delirium after cardiac surgery: a meta-analysis of randomized controlled trials. J Clin Anesth 2018; 50:33–42.
50. Tao R, Wang XW, Pang LJ, et al. Pharmacologic prevention of postoperative delirium after on-pump cardiac surgery: a meta-analysis of randomized trials. Medicine (Baltimore) 2018; 97:e12771.
Keywords:

blood pressure; cardiac surgery; cerebral tissue oxygen saturation; hemoglobin; neurological complications

Copyright © 2019 YEAR Wolters Kluwer Health, Inc. All rights reserved.